Cargando…

Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia

BACKGROUND: Since 2007, the Australian Know your numbers (KYN) program has been used in community settings to raise awareness about blood pressure and stroke. In 2011, the program was modified to include assessment for type 2 diabetes risk. However, it is unclear which approach for assessing diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilkenny, Monique F, Johnson, Roslyn, Andrew, Nadine E, Purvis, Tara, Hicks, Alison, Colagiuri, Stephen, Cadilhac, Dominique A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289299/
https://www.ncbi.nlm.nih.gov/pubmed/25427845
http://dx.doi.org/10.1186/1471-2458-14-1227
_version_ 1782352087614488576
author Kilkenny, Monique F
Johnson, Roslyn
Andrew, Nadine E
Purvis, Tara
Hicks, Alison
Colagiuri, Stephen
Cadilhac, Dominique A
author_facet Kilkenny, Monique F
Johnson, Roslyn
Andrew, Nadine E
Purvis, Tara
Hicks, Alison
Colagiuri, Stephen
Cadilhac, Dominique A
author_sort Kilkenny, Monique F
collection PubMed
description BACKGROUND: Since 2007, the Australian Know your numbers (KYN) program has been used in community settings to raise awareness about blood pressure and stroke. In 2011, the program was modified to include assessment for type 2 diabetes risk. However, it is unclear which approach for assessing diabetes risk in pharmacies is best. We compared two methods: random (non-fasting) blood glucose testing (RBGT); and the Australian type 2 diabetes risk assessment tool (AUSDRISK); according to 1) identification of ‘high risk’ participants including head-to-head sensitivity and specificity; 2) number of referrals to doctors; and 3) feasibility of implementation. METHODS: 117 Queensland pharmacies voluntarily participated and were randomly allocated to RBGT and AUSDRISK or AUSDRISK only. Although discouraged, pharmacies were able to change allocated group prior to commencement. AUSDRISK is a validated self-administered questionnaire used to calculate a score that determines the 5-year risk of developing type 2 diabetes. AUSDRISK (score 12+) or RBGT (≥5.6 mmol/I) indicates a high potential risk of diabetes. Median linear regression was used to compare the two measures. Staff from 68 pharmacies also participated in a semi-structured interview during a site visit to provide feedback. RESULTS: Data were submitted for 5,483 KYN participants (60% female, 66% aged >55 years, 10% history of diabetes). Approximately half of the participants without existing diabetes were identified as ‘high risk’ based on either RBGT or AUSDRISK score. Among participants who undertook both measures, 32% recorded a high RBGT and high AUSDRISK. There was a significant association between RBGT and AUSDRISK scores. For every one point increase in AUSDRISK score there was a half point increase in RBGT levels (coefficient 0.55, 95% CI: 0.28, 0.83). Pharmacy staff reported that AUSDRISK was a simple, low cost and efficient method of assessing diabetes risk compared with RBGT, e.g. since management of sharps is not an issue. CONCLUSIONS: In a large, community-based sample of Australians about half of the participants without diabetes were at ‘high risk ‘of developing diabetes based on either AUSDRISK or RBGT results. AUSDRISK was considered to be an acceptable method for assessing the risk of diabetes using opportunistic health checks in community pharmacies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2458-14-1227) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4289299
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42892992015-01-11 Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia Kilkenny, Monique F Johnson, Roslyn Andrew, Nadine E Purvis, Tara Hicks, Alison Colagiuri, Stephen Cadilhac, Dominique A BMC Public Health Research Article BACKGROUND: Since 2007, the Australian Know your numbers (KYN) program has been used in community settings to raise awareness about blood pressure and stroke. In 2011, the program was modified to include assessment for type 2 diabetes risk. However, it is unclear which approach for assessing diabetes risk in pharmacies is best. We compared two methods: random (non-fasting) blood glucose testing (RBGT); and the Australian type 2 diabetes risk assessment tool (AUSDRISK); according to 1) identification of ‘high risk’ participants including head-to-head sensitivity and specificity; 2) number of referrals to doctors; and 3) feasibility of implementation. METHODS: 117 Queensland pharmacies voluntarily participated and were randomly allocated to RBGT and AUSDRISK or AUSDRISK only. Although discouraged, pharmacies were able to change allocated group prior to commencement. AUSDRISK is a validated self-administered questionnaire used to calculate a score that determines the 5-year risk of developing type 2 diabetes. AUSDRISK (score 12+) or RBGT (≥5.6 mmol/I) indicates a high potential risk of diabetes. Median linear regression was used to compare the two measures. Staff from 68 pharmacies also participated in a semi-structured interview during a site visit to provide feedback. RESULTS: Data were submitted for 5,483 KYN participants (60% female, 66% aged >55 years, 10% history of diabetes). Approximately half of the participants without existing diabetes were identified as ‘high risk’ based on either RBGT or AUSDRISK score. Among participants who undertook both measures, 32% recorded a high RBGT and high AUSDRISK. There was a significant association between RBGT and AUSDRISK scores. For every one point increase in AUSDRISK score there was a half point increase in RBGT levels (coefficient 0.55, 95% CI: 0.28, 0.83). Pharmacy staff reported that AUSDRISK was a simple, low cost and efficient method of assessing diabetes risk compared with RBGT, e.g. since management of sharps is not an issue. CONCLUSIONS: In a large, community-based sample of Australians about half of the participants without diabetes were at ‘high risk ‘of developing diabetes based on either AUSDRISK or RBGT results. AUSDRISK was considered to be an acceptable method for assessing the risk of diabetes using opportunistic health checks in community pharmacies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2458-14-1227) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-27 /pmc/articles/PMC4289299/ /pubmed/25427845 http://dx.doi.org/10.1186/1471-2458-14-1227 Text en © Kilkenny et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kilkenny, Monique F
Johnson, Roslyn
Andrew, Nadine E
Purvis, Tara
Hicks, Alison
Colagiuri, Stephen
Cadilhac, Dominique A
Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia
title Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia
title_full Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia
title_fullStr Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia
title_full_unstemmed Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia
title_short Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia
title_sort comparison of two methods for assessing diabetes risk in a pharmacy setting in australia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289299/
https://www.ncbi.nlm.nih.gov/pubmed/25427845
http://dx.doi.org/10.1186/1471-2458-14-1227
work_keys_str_mv AT kilkennymoniquef comparisonoftwomethodsforassessingdiabetesriskinapharmacysettinginaustralia
AT johnsonroslyn comparisonoftwomethodsforassessingdiabetesriskinapharmacysettinginaustralia
AT andrewnadinee comparisonoftwomethodsforassessingdiabetesriskinapharmacysettinginaustralia
AT purvistara comparisonoftwomethodsforassessingdiabetesriskinapharmacysettinginaustralia
AT hicksalison comparisonoftwomethodsforassessingdiabetesriskinapharmacysettinginaustralia
AT colagiuristephen comparisonoftwomethodsforassessingdiabetesriskinapharmacysettinginaustralia
AT cadilhacdominiquea comparisonoftwomethodsforassessingdiabetesriskinapharmacysettinginaustralia